Vinyl alcohol-amino acid ester copolymer

By designing vinyl alcohol-amino acid ester copolymers and transesterification reaction technology with specific structures, the problem of insufficient performance of vinyl alcohol-amino acid ester copolymers in the prior art is solved, and the application in the medical, biological materials and agriculture fields is achieved. Excellent cell culture, biocompatibility and antibacterial properties and solubility to organic solvents.

CN119080976APending Publication Date: 2024-12-06SEKISUI CHEMICAL CO LTD +1
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
CN202411098740.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2019-05-10
Filing Date
2020-05-08
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

The existing vinyl alcohol-amino acid ester copolymers are not excellent in cell culture, biocompatibility and solubility to organic solvents, and are difficult to meet the needs of the medical, biomaterials and agriculture fields.

Method used

By designing vinyl alcohol-amino acid ester copolymers with specific structures, including controlling the content of hydrophilic and hydrophobic units, the transesterification reaction is carried out using dianionic zincate complexes to synthesize excellent cell culture and biological phase Capacitive and antibacterial vinyl alcohol-amino acid ester copolymer.

Benefits of technology

It has achieved application in the fields of medical, biomaterials and agriculture, provided cell culture, biocompatibility, antibacteriality and excellent solubility to organic solvents, and improved the biodegradability and widespread use of the materials.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119080976A_ABST
    Figure CN119080976A_ABST
Patent Text Reader

Abstract

Provided is a vinyl alcohol-amino acid ester copolymer which has excellent cell culturability, biocompatibility, antibacterial properties, solubility in organic solvents, and the like, and which can be used in the fields of medical treatment, biomaterials, and agriculture (in the fields of medicine and life science). The present invention is a vinyl alcohol-amino acid ester copolymer having units represented by formula (1), formula (2), and formula (4), in formula (2), R1 represents a hydrocarbon group that may have a substituent, and R2 and R3 each independently represent a hydrogen atom or a hydrocarbon group. In addition, R1 and R2, or R2 and R3 may be bonded to form a cyclic structure. # imgabs0 #
Need to check novelty before this filing date? Find Prior Art

Description

[0001] This application is a divisional application. The filing date of the parent application is May 8, 2020. The international application number is PCT / JP2020 / 018635. The application number entering the Chinese national phase is 202080034092.9. The name of the invention is vinyl alcohol-amino acid ester copolymer. Technical Field

[0002] The present invention relates to a vinyl alcohol-amino acid ester copolymer. Background Art

[0003] Conventionally, a large number of polymers have been used in the fields of life sciences such as medicine, cosmetics, and food containers, and most of them must be safe for use on the human body. Widely known polymers used in these fields include polystyrene, polymethyl methacrylate, polyvinyl chloride, polyvinyl alcohol, polyethylene, polypropylene, and polyacrylamide, and they are used in various forms such as particles, containers, plates, films, and tubes.

[0004] Among them, polyvinyl alcohol has attracted attention as a matrix polymer because it is biodegradable like polylactic acid and does not impose a burden on the environment when it is discarded, and is also a water-soluble polymer.

[0005] For example, Patent Document 1 describes that PVA is rendered biocompatible by introducing amines into polyvinyl alcohol. Patent Document 2 also describes amino-modified polyvinyl alcohol to which an amino group is bonded via a sulfur atom or the like.

[0006] Prior art literature

[0007] Patent Literature

[0008] Patent Document 1: Japanese Patent Application Laid-Open No. 11-302973

[0009] Patent Document 2: Japanese Patent Application Laid-Open No. 11-199632 Summary of the invention

[0010] Problems to be solved by the invention

[0011] However, when amino groups are bonded by the methods described in Patent Documents 1 and 2, the copolymer structure with amino acid ester is not formed, so the performance is insufficient. For example, it is not easy to use for applications such as regenerative medicine used in vivo that require cell culture. In addition, the affinity with biological tissues is also insufficient, and it is necessary to improve the biocompatibility.

[0012] Furthermore, no satisfactory results were obtained regarding solubility in organic solvents.

[0013] The object of the present invention is to provide a vinyl alcohol-amino acid ester copolymer which has excellent cell culturability, biocompatibility, antibacterial properties, solubility in organic solvents, etc. and can be used in the medical field, biomaterial field, and agricultural field (medicine and life science field).

[0014] Means for solving problems

[0015] The present invention is a vinyl alcohol-amino acid ester copolymer having units represented by the following formula (1) and formula (2).

[0016] The present invention is described in detail below.

[0017] [Chemistry 1]

[0018]

[0019] In formula (2), R 1 represents a hydrocarbon group optionally having a substituent, R 2 and R 3 Each independently represents a hydrogen atom or a hydrocarbon group. 1 and R 2 , or, R 2 and R 3 They are optionally bonded to form a ring structure.

[0020] The vinyl alcohol-amino acid ester copolymer of the present invention has a unit represented by the above formula (1) (hereinafter referred to as a vinyl alcohol unit).

[0021] By having such a vinyl alcohol unit, the hydrophilicity can be controlled.

[0022] The preferred lower limit of the content of the unit represented by the above formula (1) in the vinyl alcohol-amino acid ester copolymer of the present invention is 0.1 mol%, a more preferred lower limit is 0.5 mol%, a further preferred lower limit is 1 mol%, a further more preferred lower limit is 5 mol%, a particularly preferred lower limit is 10 mol%, a particularly preferred lower limit is 20 mol%, and a very preferred lower limit is 30 mol%. In addition, the preferred upper limit is 99.9 mol%, a more preferred upper limit is 99.5 mol%, a further preferred upper limit is 99 mol%, a further more preferred upper limit is 95 mol%, a particularly preferred upper limit is 90 mol%, a particularly preferred upper limit is 80 mol%, and a very preferred upper limit is 75 mol%, for example, 70 mol% or less, especially 65 mol% or less.

[0023] By setting the content in such a range, hydrophilicity, hydrophobicity, and reactivity can be controlled, and a copolymer having excellent cell culture properties, biocompatibility, antimicrobial properties, solubility in organic solvents, and the like can be obtained.

[0024] It should be noted that the content of the unit represented by the above formula (1) can be 1 H-NMR measurement (the same applies to other units).

[0025] The vinyl alcohol-amino acid ester copolymer of the present invention has a unit represented by the above formula (2) (hereinafter referred to as amino acid ester unit).

[0026] By having such an amino acid ester unit, the vinyl alcohol-amino acid ester copolymer can be provided with hitherto unknown properties such as biocompatibility, cell culturability, antimicrobial properties, and excellent solubility in organic solvents.

[0027] In the above formula (2), R 1 It represents a hydrocarbon group which may have a substituent.

[0028] By having the above-mentioned hydrocarbon group which may have a substituent, functions such as biocompatibility, cell culturing property, antibacterial property and solubility in organic solvents can be further imparted.

[0029] The above-mentioned hydrocarbon group includes an aliphatic hydrocarbon group, an alicyclic hydrocarbon group, an aromatic hydrocarbon group, and a hydrocarbon group in which two or more of the above-mentioned hydrocarbon groups are bonded to each other.

[0030] The hydrocarbon group is preferably a divalent hydrocarbon group.

[0031] Examples of the divalent hydrocarbon group include a linear or branched alkylene group having 1 to 20 carbon atoms (preferably 1 to 15, more preferably 1 to 10, further preferably 1 to 7, further more preferably 1 to 5, and particularly preferably 1 to 3). In addition, examples include a linear or branched alkenylene group having 2 to 20 carbon atoms (preferably 2 to 15, more preferably 2 to 10, further preferably 2 to 7, further more preferably 2 to 5, and particularly preferably 2 to 3), a cycloalkylene group, a cycloalkylidene group, an arylene group, a benzylidene group, and the like.

[0032] Examples of the linear or branched alkylene group having 1 to 20 carbon atoms include methylene, methylmethylene (ethylidene), ethylmethylene (propylidene), dimethylmethylene (isopropylidene), ethylmethylmethylene, ethylene, propylene, trimethylene, tetramethylene, and hexamethylene.

[0033] Examples of the linear or branched alkenylene group having 2 to 20 carbon atoms include propenylene group and the like.

[0034] Examples of the cycloalkylene group include 1,3-cyclopentylene, 1,2-cyclohexylene, 1,3-cyclohexylene, and 1,4-cyclohexylene.

[0035] Examples of the cycloalkylidene group include cyclopropylene (Japanese: シクロプロピレン), cyclopentylidene, and cyclohexylidene.

[0036] Examples of the arylene group include 1,2-phenylene, 1,3-phenylene, and 1,4-phenylene.

[0037] Examples of the substituent include an alkoxy group having 1 to 20 carbon atoms (preferably 1 to 15, more preferably 1 to 10, further preferably 1 to 7, further more preferably 1 to 5, and particularly preferably 1 to 3), and an aryloxy group having 6 to 30 carbon atoms (preferably 6 to 20, further preferably 6 to 10). Examples include an alkoxycarbonyl group having 2 to 20 carbon atoms (preferably 2 to 15, further preferably 2 to 10, further preferably 2 to 7), and an aryloxycarbonyl group having 7 to 30 carbon atoms (preferably 7 to 20, further preferably 7 to 1, further preferably 7 to 10). Examples include an acyloxy group having 1 to 20 carbon atoms (preferably 1 to 15, further preferably 1 to 10, further preferably 1 to 7, further more preferably 1 to 5, and particularly preferably 1 to 3), and an acyl group having 1 to 20 carbon atoms (preferably 1 to 15, further preferably 1 to 10, further preferably 1 to 7, further more preferably 1 to 5, and particularly preferably 1 to 3). In addition, examples include a carbamoyl group having 1 to 20 carbon atoms (preferably 1 to 15, more preferably 1 to 10, further preferably 1 to 7, further more preferably 1 to 5, and particularly preferably 1 to 3), and a sulfamoyl group having 0 to 30 carbon atoms (preferably 1 to 20, more preferably 1 to 15, further preferably 1 to 10, further more preferably 1 to 5). In addition, examples include a halogen atom, an alkylthio group having 1 to 20 carbon atoms, an arylthio group having 6 to 30 carbon atoms, an alkylsulfonyl group having 0 to 20 carbon atoms, an arylsulfonyl group having 6 to 30 carbon atoms, a phenol group, a hydroxyl group, a carboxyl group, a cyano group, a hydrazino group, a urea group having 1 to 20 carbon atoms, a thiourea group having 1 to 20 carbon atoms, and a nitro group. These substituents may be used alone or in combination of two or more. Furthermore, as the substituent, from the viewpoint of further improving biocompatibility and biodegradability, a hydrophilic functional group (for example, a hydroxyl group, a carboxyl group, a phenol group, an amino group) is preferred.

[0038] Among them, as the above R 1 From the viewpoint of further improving biocompatibility, it is preferred to use a linear or branched alkylene group having 1 to 20 carbon atoms and having a phenol group as a substituent, and a linear or branched alkylene group having 1 to 20 carbon atoms and having an alkoxycarbonyl group having 2 to 20 carbon atoms as a substituent. In addition, a linear or branched alkylene group having 1 to 20 carbon atoms and having a phenol group as a substituent is more preferred, and an ethylidene group having a phenol group as a substituent is still more preferred.

[0039] [Chemistry 2]

[0040]

[0041] In the above formula (2), the above R 2 and R 3 Each independently represents a hydrogen atom or a hydrocarbon group. 1 and R 2 , or, R 2 and R 3 They are optionally bonded to form a ring structure.

[0042] It should be noted that R 2 and R 3 The hydrocarbon group is preferably an alkyl group or an alkylene group, and the alkyl group or the alkylene group is preferably an alkyl group or an alkylene group having 1 to 20 carbon atoms.

[0043] It should be noted that in R 2 and R 3 When the two molecules are bonded to form a ring structure, R 2 and R 3 Together with the N atom, it forms a ring structure. 2 and R 3 When forming a ring structure with N atoms, R 2 and R 3 The total number of carbon atoms is preferably 2-20, more preferably 3-10, and even more preferably 4-8.

[0044] In addition, in R 1 and R 2 When the two molecules are bonded to form a ring structure, R 1 and R 2 Together with the N atom, it forms a ring structure. 1 and R 2 When forming a ring structure with N atoms, R 1 and R 2 The total number of carbon atoms is preferably 2-20, more preferably 3-10, and even more preferably 4-8.

[0045] As the above R 1 and R 2 , or, R 2 and R 3 Examples of the structure in the case of bonding to form a ring structure include pyrrolidine and piperidine.

[0046] In the present invention, among the units represented by the above formula (2), it is preferred that R 1 is a divalent hydrocarbon group which may have a substituent, R 2 and R3 is a hydrogen atom or an alkyl group, and the above R is particularly preferred 2 and R 3 All are hydrogen atoms.

[0047] The preferred lower limit of the content of the unit represented by the above formula (2) in the vinyl alcohol-amino acid ester copolymer of the present invention is 0.1 mol%, a more preferred lower limit is 0.5 mol%, a further preferred lower limit is 1 mol%, a further more preferred lower limit is 5 mol%, a particularly preferred lower limit is 10 mol%, a particularly preferred lower limit is 20 mol%, and a very preferred lower limit is 25 mol%. For example, it is 30 mol% or more, especially 35 mol% or more, and the preferred upper limit is 99.9 mol%, a more preferred upper limit is 99.5 mol%, a further preferred upper limit is 99 mol%, a further more preferred upper limit is 95 mol%, a particularly preferred upper limit is 90 mol%, a particularly preferred upper limit is 80 mol%, and a very preferred upper limit is 70 mol%.

[0048] By setting the content within such a range, functions such as biocompatibility, cell culturing properties, antimicrobial properties, and excellent solubility in organic solvents can be imparted to the vinyl alcohol-amino acid ester copolymer.

[0049] The weight average molecular weight of the vinyl alcohol-amino acid ester copolymer of the present invention is not particularly limited, but is preferably 1,000 to 1,000,000.

[0050] The degree of polymerization of the vinyl alcohol-amino acid ester copolymer of the present invention is preferably 200 to 3000, more preferably 250 to 2500, and even more preferably 300 to 2000. By setting the degree of polymerization within the above range, applicability in a wide range can be exhibited.

[0051] In the present invention, the degree of polymerization, number average molecular weight and weight average molecular weight can be measured, for example, by gel permeation chromatography using DMSO as an eluent and one Shodex LF-804 (8.0 mmID×300 ml) as a column and polyethylene glycol as a standard.

[0052] The preferred lower limit of the viscosity of the vinyl alcohol-amino acid ester copolymer of the present invention measured as a 4 wt % aqueous solution at 20° C. is 1.0 m P a ·s, the more preferred lower limit is 2.0 m P a The upper limit of the pressure is preferably 500 mPa·s, and the upper limit is more preferably 400 mPa·s. By setting the pressure within the above range, the handling property when the liquid is made into an aqueous solution can be improved.

[0053] In addition, the said viscosity can be measured according to JIS K 6726.

[0054] The vinyl alcohol-amino acid ester copolymer of the present invention preferably has a unit represented by the following general formula (3) (hereinafter also referred to as an acetal unit). If the vinyl alcohol-amino acid ester copolymer has an acetal unit, it is easy to control the hydrophilicity and hydrophobicity and can improve the strength.

[0055] [Chemistry 3]

[0056]

[0057] In the above formula (3), R 4 It represents a hydrogen atom or an alkyl group having 1 to 20 carbon atoms.

[0058] In the above formula (3), R 4 In the case of an alkyl group having 1 to 20 carbon atoms, examples of the alkyl group include methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, etc. In addition, examples include pentyl, hexyl, heptyl, 2-ethylhexyl, octyl, nonyl, decyl, undecyl, dodecyl, tridecyl, tetradecyl, pentadecyl, octadecyl, etc. Among them, from the viewpoint of improving mechanical strength, methyl and n-propyl are preferred, and n-propyl is preferred.

[0059] In the vinyl alcohol-amino acid ester copolymer of the present invention, the preferred lower limit of the content of the unit with acetal group shown in the above-mentioned general formula (3) is 0.5 mol %, the more preferred lower limit is 1.0 mol %, the further preferred lower limit is 5.0 mol %, and the further more preferred lower limit is 10.0 mol %. In addition, the preferred upper limit is 90 mol %, the more preferred upper limit is 80 mol %, the further preferred upper limit is 70 mol %, and the further more preferred upper limit is 65 mol %.

[0060] When the content of the acetal unit is not less than the above lower limit, the solubility in an organic solvent can be improved. When the content of the acetal unit is not more than the above upper limit, a polyvinyl acetal resin having excellent toughness can be obtained.

[0061] It should be noted that in this specification, as a method for calculating the content of acetal units, since the acetal group of the vinyl alcohol-amino acid ester copolymer is obtained by acetalizing a structural unit having two hydroxyl groups, the content of acetal units is calculated by counting the acetalized structural units having two hydroxyl groups.

[0062] From the viewpoint of controlling hydrophilicity and hydrophobicity and melting point, the vinyl alcohol-amino acid ester copolymer of the present invention preferably has a unit containing vinyl acetate (hereinafter also referred to as a vinyl acetate unit) represented by the following general formula (4).

[0063] [Chemistry 4]

[0064]

[0065] In the vinyl alcohol-amino acid ester copolymer of the present invention, the preferred lower limit of the content of the vinyl acetate unit represented by the general formula (4) is 0.5 mol%, a more preferred lower limit is 1.0 mol%, and a further preferred lower limit is 1.5 mol%. In addition, the preferred upper limit is 99.5 mol%, a more preferred upper limit is 99 mol%, a further preferred upper limit is 90 mol%, a further more preferred upper limit is 80 mol%, a particularly preferred upper limit is 70 mol%, and a particularly preferred upper limit is 60 mol%, for example, 50 mol% or less, particularly 30 mol% or less.

[0066] By setting it as such a range, the hydrophobicity of the vinyl alcohol-amino acid ester copolymer can be controlled.

[0067] The vinyl alcohol-amino acid ester copolymer of the present invention may further have units containing other monomers.

[0068] The above other monomers are not particularly limited, but are preferably monomers having at least one polar group and one olefinic double bond selected from the group consisting of a carboxyl group, an amide group, an epoxy group, and an ether group in the molecule. Examples of such monomers include crotonic acid, maleic acid, fumaric acid, citraconic acid, mesaconic acid, and itaconic acid.

[0069] The content of the unit containing other monomers contained in the vinyl alcohol-amino acid ester copolymer of the present invention is designed according to the application and is not particularly limited, but is preferably 20 mol% or less, more preferably 10 mol% or less, and further preferably 5 mol% or less, relative to the entire vinyl alcohol-amino acid ester copolymer.

[0070] In the vinyl alcohol-amino acid ester copolymer of the present invention, the units represented by the general formula (1) and the general formula (2), and the units represented by the general formula (3) and the general formula (4) as required, and units containing other monomers may be arranged randomly or in blocks.

[0071] As a method for producing the vinyl alcohol-amino acid ester copolymer of the present invention, for example, a method comprising the step of subjecting the raw material polyvinyl alcohol to an ester exchange reaction using a dianionic zincate complex represented by the following formula (5) (ester exchange reaction method) is preferably used.

[0072] The method for producing a vinyl alcohol-amino acid ester copolymer of the present invention (transesterification method) comprises the steps of subjecting a raw material polyvinyl alcohol to a transesterification reaction using a dianionic zincate complex represented by the following formula (5).

[0073] By using the above-mentioned dianionic zincate complex, a vinyl alcohol-amino acid ester copolymer having a predetermined vinyl alcohol unit and an amino acid ester unit can be appropriately prepared. In addition, by using the above-mentioned dianionic zincate complex, an ester exchange reaction can be performed in a very short reaction time. Specifically, with the use of CH 3 Compared with the transesterification of ONa, the reaction can be carried out in about one-tenth of the time.

[0074] [Chemistry 5]

[0075] t-Bu n R 4-n ZnM m (5)

[0076] In formula (5), n is an integer of 1 to 4, m is 1 or 2, and when n is 1 or 2, R may be the same or different and is an alkyl, alkenyl, aryl or aralkyl group having 1 to 8 carbon atoms, and M is lithium or magnesium.

[0077] Specific examples of the alkyl group, alkenyl group, aryl group and aralkyl group having 1 to 8 carbon atoms include methyl group, ethyl group, n-propyl group, isopropyl group, n-butyl group, isobutyl group, sec-butyl group, tert-butyl group, n-pentyl group, n-hexyl group, vinyl group, phenyl group and benzyl group.

[0078] The above-mentioned M represents lithium or magnesium. When M is lithium, m is 2, and when M is magnesium, m is 1.

[0079] The dianionic zincate complex represented by the above formula (5) is described in Japanese Patent Application Laid-Open No. 2004-292328 and can be obtained by the method described in the publication.

[0080] Specifically, for example, as the dilithium salt, there can be mentioned: tetra-tert-butyl zincate dilithium, tri-tert-butyl methyl zincate dilithium, tri-tert-butyl ethyl zincate dilithium, tri-tert-butyl n-propyl zincate dilithium, tri-tert-butyl n-butyl zincate dilithium, tri-tert-butyl isobutyl zincate dilithium, tri-tert-butyl sec-butyl zincate dilithium, di-tert-butyl dimethyl zincate dilithium, di-tert-butyl diethyl zincate dilithium, di-tert-butyl di-n-propyl zincate dilithium, di-tert-butyl di-n-butyl zincate dilithium, di-tert-butyl di-isobutyl zincate dilithium, di-tert-butyl di-sec-butyl zincate dilithium, tert-butyl trimethyl zincate dilithium, tert-butyl triethyl zincate dilithium, tert-butyl tri-n-propyl zincate dilithium, tert-butyl tri-n-butyl zincate dilithium, tert-butyl tri-isobutyl zincate dilithium, tert-butyl tri-sec-butyl zincate dilithium, and the like.

[0081] In addition, examples of magnesium salts include tetra-tert-butyl magnesium zincate, tri-tert-butyl methyl magnesium zincate, tri-tert-butyl ethyl magnesium zincate, tri-tert-butyl n-propyl magnesium zincate, tri-tert-butyl n-butyl magnesium zincate, tri-tert-butyl isobutyl magnesium zincate, tri-tert-butyl sec-butyl magnesium zincate, di-tert-butyl dimethyl magnesium zincate, di-tert-butyl diethyl magnesium zincate, di-tert-butyl di-n-propyl magnesium zincate, di-tert-butyl di-n-butyl magnesium zincate, di-tert-butyl di-isobutyl magnesium zincate, di-tert-butyl di-sec-butyl magnesium zincate, tert-butyl trimethyl magnesium zincate, tert-butyl triethyl magnesium zincate, tert-butyl tri-n-propyl magnesium zincate, tert-butyl tri-n-butyl magnesium zincate, tert-butyl tri-isobutyl magnesium zincate, and tert-butyl tri-sec-butyl magnesium zincate.

[0082] Among them, as the dianionic zincate complex represented by the above formula (5), it is preferable to use a dilithium salt, preferably having an alkyl group having 1 to 4 carbon atoms. In particular, dilithium tetra-tert-butyl zincate (TBZL) is preferable.

[0083] It should be noted that the above-mentioned dianionic zincate complex may be used alone or in combination of two or more.

[0084] The above-mentioned TBZL can be prepared according to the method described in Example 1 of JP-A-2004-292328.

[0085] The reaction temperature in the above-mentioned transesterification reaction is not particularly limited and can be appropriately selected from the range of -80°C to 200°C, preferably in the range of 0°C to 80°C.

[0086] The above-mentioned transesterification reaction may be carried out under normal pressure or under reduced pressure.

[0087] The reaction time of the transesterification reaction can be adjusted so as to complete the transesterification reaction, and is preferably 0.1 to 100 hours, more preferably 1 to 70 hours, and even more preferably 5 to 50 hours.

[0088] Furthermore, when the above-mentioned transesterification reaction is carried out, a method of removing the by-produced alcohol by azeotropic distillation with an organic solvent can also be adopted.

[0089] In the above-mentioned transesterification reaction, the amount of the dianionic zincate catalyst is preferably 0.001 mol and 0.5 mol relative to 1 mol of the vinyl alcohol unit in the raw material polyvinyl alcohol. The more preferred lower limit is 0.001 mol, the more preferred upper limit is 0.1 mol, the further preferred lower limit is 0.005 mol, and the further preferred upper limit is 0.05 mol.

[0090] The step of performing transesterification using the dianionic zincate complex is preferably performed by, for example, dissolving the raw material polyvinyl alcohol in a solvent, adding the dianionic zincate complex and an amino acid ester compound to perform transesterification, and further adding an acid to stop the transesterification reaction.

[0091] The solvent is not particularly limited, and examples thereof include toluene, dimethyl sulfoxide, acetone, diethyl ether, tetrahydrofuran, water, and mixed solvents thereof.

[0092] Examples of the amino acid ester compound include glycine alkyl esters, aspartic acid acrylate, L-tyrosine methyl ester, L-methionine methyl ester, L-methionine ethyl ester, DL-2-aminobutyric acid methyl ester, L-alanine methyl ester, N-Boc-glycine methyl ester, β-alanine methyl ester, N-benzyloxycarbonylglycine methyl ester, L-tert-leucine methyl ester, 2-piperidinic acid methyl ester, 2-piperidinic acid ethyl ester, 4-piperidinic acid methyl ester (isopiperidinic acid methyl ester), 4-piperidinic acid ethyl ester, DL-pyroglutamic acid methyl ester. , 1-methyl L-glutamate, 1-methyl L-aspartic acid, methyl 3-aminobenzoate, methyl 2-aminothiophene-3-carboxylate, methyl 2-amino-4,5-difluorobenzoate, methyl 4-aminobenzoate, methyl 1-aminocyclopropanecarboxylate, methyl 1-aminocyclohexanecarboxylate, methyl 1-amino-1-cyclopentanecarboxylate, methyl 5-amino-2,4-difluorobenzoate, methyl 3-aminopyrazole-4-carboxylate, methyl 2-(acetylamino)isonicotinate, methyl 5-amino-2-furoate, etc.

[0093] In the above-mentioned step of conducting the transesterification reaction, a carrier such as a molecular sieve may be added.

[0094] By adding the above-mentioned carrier, adsorption to the carrier occurs, and the chemical equilibrium is tilted. As a result, the carrier functions as a reaction aid.

[0095] As the molecular sieve, zeolite is preferably used, and examples thereof include molecular sieve 3A and molecular sieve 4A, and preferably, molecular sieve 4A is used.

[0096] The above-mentioned step of conducting the transesterification reaction may be carried out in a homogeneous system or in a heterogeneous system.

[0097] It should be noted that a homogeneous system refers to a system in which a substance exists at a uniform concentration, and refers to a state in which the components are dissolved in a solvent. An inhomogeneous system refers to a situation in which the reaction system is inhomogeneous, and refers to a system in which a substance exists locally as the reaction proceeds, and refers to a state in which a part of the components such as resins are not dissolved during the reaction.

[0098] The vinyl alcohol-amino acid ester copolymer of the present invention can be used, for example, as a viscosity adjuster for aqueous solutions, a gas barrier coating agent, a suspending agent, an emulsifier, a polarizing plate, a water-soluble film, a dispersant, a cell culture medium, a biomaterial, an agricultural film, and a raw material for various resins such as an antibacterial resin.

[0099] The form of the vinyl alcohol-amino acid ester copolymer of the present invention is not particularly limited, and various forms such as fibers, cloths such as nonwoven fabrics, nets, films, coatings, sheets, blocks, particles, rods, plates, sponges, solutions, coatings, gels, and creams can be cited. Among them, cloths such as nonwoven fabrics, sheets, coatings, and particles are preferred. In addition, a method of dissolving or dispersing in a mixture of water or an organic solvent such as alcohol and water and spraying can also be preferably used.

[0100] The vinyl alcohol-amino acid ester copolymer of the present invention can be advantageously used, for example, in the above-mentioned form as a cell culture medium, a biomaterial, an agricultural film, or an antimicrobial agent.

[0101] Effects of the Invention

[0102] According to the present invention, a vinyl alcohol-amino acid ester copolymer can be provided which has excellent cell culturability, biocompatibility, antibacterial properties, solubility in organic solvents, etc. and can be applied to the medical field, biomaterial field, and agricultural field (medicine and life science field). DETAILED DESCRIPTION

[0103] Hereinafter, the present invention will be described in more detail with reference to Examples, but the present invention is not limited to these Examples.

[0104] (Example 1)

[0105] 1 part by weight of raw material polyvinyl alcohol (PVA-1, saponification degree 98.5, polymerization degree 300) was added to 49 parts by weight of DMSO to dissolve it (concentration 2% by weight). Then, 4.4 parts by weight of L-tyrosine methyl ester and 6 parts by weight of tetra-tert-butyl zincate dilithium (TBZL, solvent: tetrahydrofuran, concentration 13% by weight) were added, and stirred at 30° C. for 6 hours to carry out an ester exchange reaction.

[0106] Then, the product (vinyl alcohol-amino acid ester copolymer) was obtained by reprecipitating in tetrahydrofuran and washing with tetrahydrofuran.

[0107] (Example 2)

[0108] A product (vinyl alcohol-amino acid ester copolymer) was obtained by the same method as in Example 1 except that the stirring time in the transesterification reaction was changed from "6 hours" to "24 hours".

[0109] (Example 3)

[0110] A product (vinyl alcohol-amino acid ester copolymer) was obtained by the same method as in Example 1 except that the amount of L-tyrosine methyl ester added was changed from "4.4 parts by weight" to "8.9 parts by weight".

[0111] (Example 4)

[0112] A product (vinyl alcohol-amino acid ester copolymer) was obtained by the same method as in Example 1 except that the amount of L-tyrosine methyl ester added was changed from "4.4 parts by weight" to "17.7 parts by weight".

[0113] (Example 5)

[0114] A product (vinyl alcohol-amino acid ester copolymer) was obtained by the same method as in Example 4 except that the stirring time in the transesterification reaction was changed from "6 hours" to "24 hours" and reprecipitation and washing were performed with water.

[0115] (Example 6)

[0116] The product (vinyl alcohol-amino acid ester copolymer) was obtained by the same method as in Example 5 except that the raw material polyvinyl alcohol (PVA-3, saponification degree 98.5, polymerization degree 600) was used instead of the raw material polyvinyl alcohol (PVA-1, saponification degree 98.5, polymerization degree 300).

[0117] (Example 7)

[0118] The product (vinyl alcohol-amino acid ester copolymer) was obtained by the same method as in Example 5 except that the raw material polyvinyl alcohol (PVA-4, saponification degree 98.5, polymerization degree 1000) was used instead of the raw material polyvinyl alcohol (PVA-1, saponification degree 98.5, polymerization degree 300).

[0119] (Example 8)

[0120] 1 part by weight of the raw material polyvinyl butyral (PVB, 34 mol% of vinyl alcohol unit, 65 mol% of acetal unit, 1 mol% of vinyl acetate unit, degree of polymerization 1700) was added to 19 parts by weight of DMSO to dissolve it (concentration 5 wt%). Then, 2.5 parts by weight of L-tyrosine methyl ester and 0.25 parts by weight of tetra-tert-butyl zincate dilithium (TBZL, concentration 13 wt%) were added, and stirred at 30° C. for 6 hours to carry out an ester exchange reaction.

[0121] Then, the product (vinyl butyral-amino acid ester copolymer) was obtained by reprecipitation in water and washing with hot water.

[0122] (Example 9)

[0123] The product (vinyl alcohol-amino acid ester copolymer) was obtained by the same method as in Example 1, except that 4-CEP (ethyl 4-piperidinylcarboxylate) was used instead of L-tyrosine methyl ester, the amount of TBZL (concentration 13 wt%) added in the ester exchange reaction was changed from "6 parts by weight" to "10 parts by weight", and the stirring time was changed from "6 hours" to "24 hours".

[0124] (Example 10)

[0125] A product (vinyl alcohol-amino acid ester copolymer) was obtained by the same method as in Example 9 except that the amount of 4-CEP (ethyl 4-piperidincarboxylate) added was changed from "4.4 parts by weight" to "17.7 parts by weight".

[0126] (Example 11)

[0127] The product (vinyl alcohol-amino acid ester copolymer) was obtained by the same method as in Example 10 except that the raw material polyvinyl alcohol (PVA-3, saponification degree 98.5, polymerization degree 600) was used instead of the raw material polyvinyl alcohol (PVA-1, saponification degree 98.5, polymerization degree 300).

[0128] (Example 12)

[0129] The product (vinyl alcohol-amino acid ester copolymer) was obtained by the same method as in Example 10 except that the raw material polyvinyl alcohol (PVA-4, saponification degree 98.5, polymerization degree 1000) was used instead of the raw material polyvinyl alcohol (PVA-1, saponification degree 98.5, polymerization degree 300).

[0130] (Example 13)

[0131] A product (vinyl alcohol-amino acid ester copolymer) was obtained by the same method as in Example 8 except that 4-CEP (4-piperidinylcarboxylic acid ethyl ester) was used instead of L-tyrosine methyl ester.

[0132] (Reference example)

[0133] The product (vinyl alcohol-amino acid ester copolymer) was obtained by the same method as in Example 1, except that 2-CEP (ethyl 2-piperidinylcarboxylate) was used instead of L-tyrosine methyl ester, the amount of TBZL (concentration 13 wt%) added in the ester exchange reaction was changed from "6 parts by weight" to "10 parts by weight", and the stirring time was changed from "6 hours" to "24 hours".

[0134] (Comparative Example 1)

[0135] A vinyl alcohol-vinyl acetate copolymer (PVA-1) having a saponification degree of 98.5 and a polymerization degree of 300 was used.

[0136] (Comparative Example 2)

[0137] A vinyl alcohol-vinyl acetate copolymer (PVA-2) having a saponification degree of 88.0 and a polymerization degree of 600 was used.

[0138] (Comparative Example 3)

[0139] A vinyl alcohol-vinylamine copolymer (amine-modified PVA-1, vinylamine unit content 12 mol %) having a saponification degree of 99.5 and a polymerization degree of 1000 was used.

[0140] (Comparative Example 4)

[0141] A vinyl alcohol-vinylamine copolymer (amine-modified PVA-2, vinylamine unit content 6 mol %) having a saponification degree of 99.5 and a polymerization degree of 500 was used.

[0142] (Evaluation method)

[0143] The products obtained above were evaluated by the following methods. The results are shown in Table 1.

[0144] (1) 1 H-NMR measurement

[0145] By subjecting the obtained product to 1 H-NMR measurement was used to determine the composition ratio of the product (vinyl alcohol unit, amino acid ester unit, acetal unit, vinyl acetate unit, and vinylamine unit). 1 For H-NMR measurement, JEOL JNM-ECX500 was used, and DMSO-d 6 The solution (1 wt / vol%) was measured at 60°C.

[0146] (2) Cell culture evaluation

[0147] The obtained product was dissolved in DMSO and dried, and then coated on the bottom of a 96-well plate. Dulbecco's modified Eagle's medium (DMEM) supplemented with 5% fetal bovine serum (FBS) was used as a culture medium, and 1×10 4 Mouse fibroblast cell line (NIH / 3T3 cells) was used and incubated in 5% CO 2 The cells were cultured in an incubator at 37° C. / 10° C. Then, the initial adhesion on the first day of culture and the time-dependent proliferation and adhesion maintenance on the fourth day of culture were evaluated as shown below.

[0148] The ratio of the number of viable cells after culture to the number of seeded cells was calculated using a disposable cell counting plate (manufactured by Wakenbtech). The cell culturability was evaluated based on the obtained ratio of the number of viable cells using the following criteria.

[0149] Initial adhesion (Day 1)

[0150] ○ ○ ○: The ratio of the number of viable cells after culture to the number of seeded cells is 1.5 or more

[0151] ○ ○: The ratio of the number of viable cells after culture to the number of seeded cells is 1.0 or more and less than 1.5

[0152] ○: The ratio of the number of viable cells after culture to the number of seeded cells is 0.5 or more and less than 1.0

[0153] Δ: The ratio of the number of viable cells after culture to the number of seeded cells is 0.2 or more and less than 0.5

[0154] ×: The ratio of the number of viable cells after culture to the number of seeded cells is less than 0.2

[0155] Proliferation and adhesion maintenance over time (Day 4)

[0156] ○ ○ ○: The ratio of the number of viable cells after culture to the number of seeded cells is 3.0 or more

[0157] ○○: The ratio of the number of viable cells after culture to the number of seeded cells is 2.5 or more and less than 3.0

[0158] ○: The ratio of the number of viable cells after culture to the number of seeded cells is 2.0 or more and less than 2.5

[0159] Δ: The ratio of the number of viable cells after culture to the number of seeded cells is 1.0 or more and less than 2.0

[0160] ×: The ratio of the number of viable cells after culture to the number of seeded cells is less than 1.0

[0161] (3) Biocompatibility evaluation

[0162] The evaluation was performed by measuring ATP after 1 day and 6 days in the above cell culturing evaluation. The culture medium was removed from the wells after culture, and after washing with phosphate buffer, 100 μl of ATP extraction reagent (Intracellular AT Passay kit ver. 2: manufactured by TOYOB-net) was added, and the solution was pipetted 5 times. After standing at room temperature for 5 minutes, ATP was extracted. 1010 μL was taken out from the above ATP extraction solution, 100 μL of ATP luminescent reagent (same kit) was added and stirred, and the luminescence was measured using Mithras LB940 (manufactured by Berthold).

[0163] The cytotoxicity was calculated from the measured luminescence amount using the following formula and evaluated according to the following criteria.

[0164] Cytotoxicity = (luminescence after 6 days of culture) / (luminescence after 1 day of culture) × 100

[0165] ○: Cytotoxicity less than 30%

[0166] ×: Cytotoxicity is 30% or more

[0167] (4) Thrombus adhesion

[0168] The obtained product was dissolved in DMSO, spray-coated and dried, and then coated on the inner surface of a PET test tube (control) with an inner diameter of 10 mm and a length of 100 mm. 1 mL of human blood was added to the PET tube, the mouth was sealed and the tube was inverted for mixing so that the entire inner surface of the PET tube was wetted with blood.

[0169] Place the tube upright and allow it to stand at room temperature for about 4 hours. After confirming that the blood has coagulated, centrifuge it at 1500G for 5 minutes in a centrifuge. Then observe the amount of blood adhering to the inner surface of the top space of the PET tube (the part with a pink or light red extremely thin film).

[0170] The intensity of redness and the degree of adhesion area were comprehensively judged, and the adhesion was rated as ○, Δ, and × in order from less to more for relative evaluation.

[0171] (5) Solubility in organic solvents

[0172] Toluene (70° C.) was added to the products obtained in Examples 1 to 7, 9 to 12, and Comparative Examples 1 to 4 (PVA products), and butanol (room temperature) was added to the products obtained in Examples 8 and 13 (PVB products) to adjust the product concentration to 1.0 mass %. Then, the mixture was stirred at 500 rpm for 6 hours, and the solubility was evaluated based on the content of undissolved matter according to the following criteria.

[0173] ○: Undissolved matter is less than 20% by mass

[0174] ×: Undissolved matter is 20% by mass or more

[0175] [Table 1]

[0176]

[0177] Industrial Applicability

[0178] According to the present invention, a vinyl alcohol-amino acid ester copolymer having excellent cell culturability, biocompatibility, antibacterial property, solubility in organic solvents, etc. and applicable to the medical field, biomaterial field, and agricultural field (medicine and life science field) can be provided.

Claims

1. A vinyl alcohol-amino acid ester copolymer, comprising units represented by the following formula (1) and formula (2), wherein the content of the unit represented by the formula (2) is 5 mol% to 99.9 mol%, and further comprising units represented by the following formula (4), wherein the content of the unit represented by the following formula (4) is 1.5 mol% or more, In formula (2), R 1 represents a hydrocarbon group optionally having a substituent, R 2 and R 3 Each independently represents a hydrogen atom or a hydrocarbon group, and R 1 With R 2 , or R 2 With R 3 Optionally bonded to form a ring structure, 2. The vinyl alcohol-amino acid ester copolymer according to claim 1, in, The content of the unit represented by the formula (1) is 0.1 mol% to 95 mol%.

3. The vinyl alcohol-amino acid ester copolymer according to claim 1 or 2, in, The content of the unit represented by the formula (2) is 5 mol% to 99.5 mol%.

4. The vinyl alcohol-amino acid ester copolymer according to claim 1 or 2, which has a degree of polymerization of 200 to 3000.

5. The vinyl alcohol-amino acid ester copolymer according to claim 1 or 2, further comprising a unit represented by the following formula (3): In formula (3), R 4 It represents a hydrogen atom or an alkyl group having 1 to 20 carbon atoms.

6. The vinyl alcohol-amino acid ester copolymer according to claim 5, in, The content of the unit represented by the formula (3) is 0.5 mol% to 90 mol%.

7. The vinyl alcohol-amino acid ester copolymer according to claim 1 or 2, in, In the unit represented by formula (2), R 1 is a divalent hydrocarbon group which may have a substituent, R 2 and R 3 is a hydrogen atom or an alkyl group.

8. The vinyl alcohol-amino acid ester copolymer according to claim 1 or 2, in, The content of the unit represented by the formula (4) is 1.5 mol% to 90 mol%. 9 . A cell culture medium comprising the vinyl alcohol-amino acid ester copolymer according to claim 1 .

10. A biomaterial using the vinyl alcohol-amino acid ester copolymer according to claim 1 or 2.

Citation Information

Patent Citations

  • Production of amino group-modified polyvinyl alcohol

    JP1999199632A

  • Polyvinyl alcohol-based hollow yarn with excellent biocompatibility nd its production

    JP1999302973A

  • Organozinc complex and method for producing the same

    JP2004292328A